Dr. Michael Har-Noy

Dr. Michael Har-Noy is the Chief Executive Officer and Director of Mirror Biologics, Ltd., a role he has held since January 2021. He is also the founder and CEO of Mirror Biologics, Inc., which focuses on developing innovative therapeutic cancer vaccines that are both "off-the-shelf" and personalized for advanced solid tumors. His work involves the commercialization of products developed by Immunovative Therapies, Ltd., where he has been a founder and CEO since May 2004.1

Professional Background

• Mirror Biologics, Ltd.: As CEO, Dr. Har-Noy oversees the GMP manufacturing and formulation of living immune cell biological products and related R&D.
• Immunovative Therapies Ltd.: In this role, he has led efforts in discovering immunotherapy drugs utilizing living immune cells for treating cancer and infectious diseases.
• Immunovative Clinical Research, Inc.: He serves as President and Chief Medical Officer, providing clinical research and regulatory consulting services.

Contributions to Biotechnology

Dr. Har-Noy is recognized for his contributions to the field of biotechnology, particularly in developing automated processes for producing living cell products. His expertise extends to designing bioreactors and ensuring compliance with regulatory standards for clinical research.1

He is based in Wesley Chapel, Florida, but also has significant ties to Jerusalem, Israel, where he conducts much of his research and business operations.1